Dr. David L. Grinblatt, MD

Dr. Grinblatt practices at Evanston Hospital in Evanston, Illinois, part of Endeavor Health.

Dr. Grinblatt's NPI, 1548285372, was assigned on July 13, 2006. Dr. Grinblatt graduated from Cleveland Medical College, Homeopathic in 1986. Dr. Grinblatt holds Illinois license 036077054.

Dr. Grinblatt's primary practice is Evanston Hospital, at 2650 Ridge Ave, Evanston, IL 60201 in Cook County. The practice phone is (847) 570-2000.

Dr. Grinblatt's primary practice is Evanston Hospital in Evanston, Illinois, part of Endeavor Health. Dr. Grinblatt is also affiliated with Swedish Hospital. The medical group on file is Endeavor Health Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grinblatt practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Grinblatt's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Grinblatt is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Grinblatt's licenses on file in 2 states: Illinois and Ohio.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), immune deficiency disease, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Grinblatt treats.

CMS data shows 2,271 Medicare services from Dr. Grinblatt across 10 procedure codes in 2024, for 569 Medicare patients. Medicare paid $147,989 for them.

CMS counts 569 Medicare patients who saw Dr. Grinblatt in 2024. The largest group is 75 to 84, with 238 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 8% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grinblatt's median patient age at 71, with 52% women.

In 2024, Dr. Grinblatt wrote 1,922 Medicare Part D claims for 223 patients. 70% of them were for generic drugs. CMS names the drug for 1,638 of them, across 33 drugs with 11 or more claims each, at $7,745,811 in total drug cost. In 2023, CMS named 1,505 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Grinblatt for performance year 2024, reported as part of a group. Dr. Grinblatt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grinblatt as offering telehealth.

Dmand AI links 32 papers to Dr. Grinblatt, published from 2006 to 2025. 2017 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Hematopoietic Stem Cell Transplantation and Antigens, CD34. Dr. Grinblatt has published most often in Bone Marrow Transplant. Dr. Grinblatt's most frequent co-authors are Nicole Lamanna, MD, Matthew S. Davids, MD and Charles M. Farber, MD, PhD.

Dmand AI links Dr. Grinblatt to 8 clinical trials, 4 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Lymphoma, Follicular, Myelodysplastic Syndromes and Bone Marrow Diseases. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 378 general payments to Dr. Grinblatt from 18 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 38% of the total. Alexion Pharmaceuticals, Inc. paid the most, $180,099. It also lists 14 research payments totaling $26,750 from 2016 to 2022.

Dmand AI lists 2 awards for Dr. Grinblatt, most recently CMS Stage 1 EHR in 2013.

Dr. Grinblatt graduated from Cleveland Medical College, Homeopathic in 1986. Dr. Grinblatt is a member of ASCO.

Dr. Grinblatt is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.